Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Atorvastatin for the Treatment of Retinal Vein Occlusion (ATORVO)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2008 by University of Toronto.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
St. Michael's Hospital, Toronto
Pfizer
Canadian Heart Research Centre
Ontario Association of Optometrists
Toronto Ophthalmological Society
Information provided by:
University of Toronto
ClinicalTrials.gov Identifier:
NCT00517257
First received: August 14, 2007
Last updated: June 23, 2008
Last verified: June 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2009
  Estimated Primary Completion Date: No date given